Schlagwort: pancreatic cancer
Nanoparticles for optimized cancer therapy
Distinct classes of fibroblasts in tumors play opposing roles, promoting or restraining pancreatic cancer growth
Could diet modification make chemotherapy drugs more effective for patients with pancreatic cancer?
Novel treatment makes pancreatic cancer susceptible to immunotherapy, mouse study shows
Pancreatic cancer cells feed off hyaluronic acid
Researchers identify signaling mechanisms in pancreatic cancer cells that could provide treatment targets
The subtle difference: Pancreatic tumor organoids pave the way for single-cell diagnostics
Experimental drug boosts immunotherapy effectiveness in pancreatic cancer in mice
Scientists reverse pancreatic cancer progression in ‘time machine’ made of human cells
Lab grown tumor models could improve treatment for pancreatic cancer
Link between inflammation and pancreatic cancer development uncovered
Engineers grow pancreatic ‚organoids‘ that mimic the real thing
Pumping iron: Inhibition of key pathway promotes iron-dependent cell death in pancreatic cancer cells
New drug combo shows early potential for treating pancreatic cancer
How pancreatic cancer cells dodge drug treatments
Scientists show how to attack the ‚fortress‘ surrounding pancreatic cancer tumors
PARP inhibitor shrinks tumors in pancreatic cancer patients with mutations
Immune-stimulating drug before surgery shows promise in early-stage pancreatic cancer
Pancreatic cancer tumors use multiple mechanisms to avoid starvation: new target for treatment?
Scientists shrink pancreatic tumors by starving their cellular ’neighbors‘
Therapy sneaks into hard layer of pancreatic cancer tumor and destroys it from within
Investment needed to bring down pancreatic cancer death rates in Europe
Drug is promising against pancreatic and breast cancers
A global assessment of cancer genomic alterations in epigenetic mechanisms
Muhammad A Shah, Emily L Denton, Cheryl H Arrowsmith, Mathieu Lupien and Matthieu Schapira
Abstract
Background
The notion that epigenetic mechanisms may be central to cancer initiation and progression is supported by recent next-generation sequencing efforts revealing that genes involved in chromatin-mediated signaling are recurrently mutated in cancer patients.
Results
Here, we analyze mutational and transcriptional profiles from TCGA and the ICGC across a collection 441 chromatin factors and histones. Chromatin factors essential for rapid replication are frequently overexpressed, and those that maintain genome stability frequently mutated. We identify novel mutation hotspots such as K36M in histone H3.1, and uncover a general trend in which transcriptional profiles and somatic mutations in tumor samples favor increased transcriptionally repressive histone methylation, and defective chromatin remodeling.
Conclusions
This unbiased approach confirms previously published data, uncovers novel cancer-associated aberrations targeting epigenetic mechanisms, and justifies continued monitoring of chromatin-related alterations as a class, as more cancer types and distinct cancer stages are represented in cancer genomics data repositories.
Continue reading „A global assessment of cancer genomic alterations in epigenetic mechanisms“ →